Sentry is a lateral plate that has a low profile, intuitive design with a cam locking mechanism which allows the system to provide visual, tactile and audible confirmation of final locking.
The product rounds out Life Spine's full procedural offering for eLIF lateral fusion which consists of the Longbow Expandable Spacer, Centric Expandable Retractor System, Osteo-Link biologics, Plateau-X Lateral Spacer System and an integrated full line neuromonitoring system.
Sentry is scheduled for full product release by the end of 2016.
Life Spine, which is privately held, is based in Huntley, Illinois.
TiumBio files Clinical Trial Application to start Phase 1b TU7710 study
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
argenx obtains VYVGART approval for primary immune thrombocytopenia in Japan
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval